ENTITY
Celltrion

Celltrion (068270 KP)

25
Analysis
Health Care • South Korea
Celltrion, Inc. produces and sells biosimilar products, as well as consignment processing services for other businesses.
more
bearish•Samsung Biologics
•04 Oct 2016 07:43

Samsung BioLogics IPO Price, Capital Investment Plan & Valuation Issue

In a regulatory filing (last Friday), Samsung Biologics announced its plan to raise â‚©1.23tril (US$1.12bil) of new shares. Samsung BioLogics plans...

Logo
371 Views
Share
•04 Oct 2016 03:57

Korea Stock Market Monthly Recap #6 - (September 2016)

The six major events in the Korea Stock Market in September were as follows: LG Chem-LG Life Sciences merger, Hanjin Shipping applying for court...

Logo
270 Views
Share
•17 Sep 2016 22:47

Korea's Foreign Direct Investment Trend

LS Cable & System Asia Ltd (229640 KS) and Hwaseung Enterprise Co. are two Vietnam related stocks that will be listed on the Korea Stock Market...

Logo
283 Views
Share
bearish•Celltrion Inc
•16 Sep 2016 06:18

More Harsh Reality from Teva

U.S. healthcare industry leaders from across the spectrum of industry segments continue to downplay the near-term adoption of biosimilars in the...

Share
•12 Sep 2016 01:15

John Lee's Vietnam Fund

Vietnam has been one of the hottest destinations among Korean investors in 2016. Among overseas net investment fund flows, Vietnam experienced the...

Logo
406 Views
Share
x